PB2122: THE EFFICACY OF THE STANDARD AND INTENSIVE CHEMOTHERAPY IN ELDERLY PATIENTS WITH DOUBLE- AND TRIPLE-EXPRESSOR LYMPHOMA.

PB2122: THE EFFICACY OF THE STANDARD AND INTENSIVE CHEMOTHERAPY IN ELDERLY PATIENTS WITH DOUBLE- AND TRIPLE-EXPRESSOR LYMPHOMA.

Bibliographic Details
Main Authors:	M. Fujita, H. Itamura, M. miyazaki, K. Ishii, A. Sugihara, H. Sano, S. Okamoto, M. yoshimura, H. Katsuya, H. Ureshino, T. Ando, S. Kimura
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000851320.93038.b4

Similar Items

2122
by: Lisa M. Shandley, et al.
Published: (2017-09-01)

Double or triple-expressor lymphomas: prognostic impact of immunohistochemistry in patients with diffuse large B-cell lymphoma
by: Camila Peña, et al.
Published: (2020-04-01)

Higher neutrophil counts are associated with successful tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia
by: Hiroshi Ureshino, et al.
Published: (2022-12-01)

Clinical features and therapy of double-hit and double-expressor lymphomas
by: E A Baryakh, et al.
Published: (2016-12-01)

Case Report: Concurrent Occurrence of Abdominal Double Expressor Lymphoma and Jejunum Follicular Lymphoma
by: Ryutaro Takada, et al.
Published: (2021-05-01)

Multiple osteolytic lesions due to Double-Expressor Primary non‑Hodgkin Lymphoma of the Bone
by: Sotirios Papageorgiou, et al.
Published: (2021-07-01)

IEEE Access™ Editorial Board
Published: (2022-01-01)

IEEE Access™ Editorial Board
Published: (2015-01-01)

Assessment of CD52 expression in "double-hit" and "double-expressor" lymphomas: Implications for clinical trial eligibility.
by: Jeffrey W Craig, et al.
Published: (2018-01-01)

HTLV‐1 cell‐free DNA in plasma as a potential biomarker in HTLV‐1 carriers and adult T‐cell leukemia‐lymphoma
by: Hiroo Katsuya, et al.
Published: (2023-08-01)

Outcomes of patients with double/triple expressor diffuse large B-cell lymphoma (DLBCL) treated with R-DA-EPOCH/R-CHOP: A single-center experience.
by: Kanta Devi, et al.
Published: (2021-01-01)

Helicobacter cinaedi bacteremia in a patient with primary central nervous system lymphoma
by: Mai Fujita, et al.
Published: (2021-11-01)

TREATMENT OUTCOMES AND CLINICAL RELEVANCE IN PATIENTS WITH DOUBLE EXPRESSOR DLBCL
by: PIMJAI NIPARUCK
Published: (2021-10-01)

2122 3D STAR non-contrast carotid MR angiography
by: Li Wei, et al.
Published: (2008-10-01)

Prognostic evaluation of system immune-inflammatory index and prognostic nutritional index in double expressor diffuse large B-cell lymphoma
by: Su Fang, et al.
Published: (2023-10-01)

Immunohistochemical Characterisation of Cell of Origin in Diffuse Large B-cell Lymphoma and its Association with the Double Expressor Phenotype: A Retrospective Study
by: Prachi, et al.
Published: (2022-05-01)

Enhanced lipid metabolism confers the immunosuppressive tumor microenvironment in CD5-positive non-MYC/BCL2 double expressor lymphoma
by: Meng-Ke Liu, et al.
Published: (2022-10-01)

IEEE <italic>Access</italic><sup>™</sup> Editorial Board
Published: (2023-01-01)

Alveolar rhabdomyosarcoma with massive bone marrow infiltration and disseminated intravascular coagulation mimicking acute leukemia
by: Ayano Sugihara, et al.
Published: (2022-08-01)

Venetoclax improves CD20 immunotherapy in a mouse model of MYC/BCL2 double-expressor diffuse large B-cell lymphoma
by: Patricia Pérez-Galán, et al.
Published: (2023-02-01)

Characteristics of CD5-positive diffuse large B-cell lymphoma among Koreans: High incidence of BCL2 and MYC double-expressors.
by: Hee Young Na, et al.
Published: (2019-01-01)

Primary, non-germinal center, double-expressor diffuse large B cell lymphoma confined to a uterine leiomyoma: A case report
by: Alexandra Martin, et al.
Published: (2017-11-01)

STUDIES ON 2,122 CASES WITH HIGH BLOOD PRESSURE AMONG 14,102 PATIENTS TREATED IN TEACHING HOSPITALS ON ISFAHAN UNIVERSITY
by: A.Sadeghi, et al.
Published: (1977-03-01)

Mandibular ramus as a strong expressor of sex determinations: A digital radiographic study
by: Ramneet Kaur, et al.
Published: (2021-01-01)

Home blood pressure monitoring schedule: optimal and minimum based on 2122 individual participants' data
by: Kyriakoulis, KG, et al.
Published: (2022)

Novel miR-b2122 regulates several ALS-related RNA-binding proteins
by: Zachary C. E. Hawley, et al.
Published: (2017-10-01)

Mobility Analytics of Fans During the 2021 FIFA Arab Cup™ Football Tournament in Qatar
by: Jassuer Abidi, et al.
Published: (2023-01-01)

2122 Perspectives on increasing competency in using digital practices and approaches to enhance clinical translational research: A qualitative study
by: Katja Reuter, et al.
Published: (2018-06-01)

Clinical and pathological characteristics of patients with double expressor diffuse large B-cell lymphomas (DLBCLs) not otherwise specified (NOS), diagnosed at Hospital San José de Bogotá, Colombia
by: Daniel Lorenzo Espinosa Redondo, et al.
Published: (2023-07-01)

Case report: Successful management of a refractory double-expressor diffuse large B-cell lymphoma patient under the guidance of in vitro high-throughput drug sensitivity test
by: Lijie Xing, et al.
Published: (2023-01-01)

Optimising SD Saving Events to Maximise Battery Lifetime for Arduino™/Atmega328P Data Loggers
by: Luke J. Bradley, et al.
Published: (2020-01-01)

Discovery of UPSTREAM OF FLOWERING LOCUS C (UFC) and FLOWERING LOCUS C EXPRESSOR (FLX) in Gladiolus ×hybridus, G. dalenii
by: Jaser A. Aljaser, et al.
Published: (2022-01-01)

Investigation of clinical interaction between omeprazole and tacrolimus in CYP3A5 non-expressors, renal transplant recipients
by: Paraskevi F Katsakiori, et al.
Published: (2010-06-01)

Do Double-Expressor High-Grade B-Cell Lymphomas Really Need Intensified Treatment? A Report from the Real-Life Series of High-Grade B-Cell Lymphomas Treated with Different Therapeutic Protocols at the Institute of Oncology Ljubljana
by: Lučka Boltežar, et al.
Published: (2024-01-01)

Third Generation PRESiCE™ Technology for Manufacturing SiC Power Devices in a 6-Inch Commercial Foundry
by: B. Jayant Baliga
Published: (2020-01-01)

Association of HLA-G Low Expressor Genotype with Severe Acute Graft-versus-Host Disease after sibling Bone Marrow Transplantation
by: Wahid eBoukouaci, et al.
Published: (2011-12-01)

PB2122: A PHASE 1/2 MULTI-CENTER, DOSE-FINDING STUDY INVESTIGATING THE SAFETY, TOLERABILITY, PK AND EFFICACY OF ZN-D5, A NOVEL BCL-2 INHIBITOR, IN PATIENTS WITH RELAPSED/REFRACTORY AL AMYLOIDOSIS
by: Efstathios Kastritis, et al.
Published: (2023-08-01)

PB2255: ASSESSMENT OF CHEMOTHERAPY-INDUCED TOXICITY IN CHILDREN WITH HODGKIN LYMPHOMA RECEIVING THE EURONET PROTOCOL
by: Hala Bekhit, et al.
Published: (2023-08-01)

The reasons for triple therapy in stable COPD patients in Japanese clinical practice
by: Miyazaki M, et al.
Published: (2015-06-01)

PB2158: EXPLORING THE BIOLOGICAL ROLE OF LILRA4 IN MANTLE CELL LYMPHOMA
by: M. K. Blum, et al.
Published: (2022-06-01)